Healthcare &
Life Sciences Infrastructure

Healthcare &
Life Sciences Infrastructure

Healthcare &
Life Sciences Infrastructure

Temperature integrity. Clinical certainty.

Good Distribution Practice (GDP)-compliant storage and validated transport for biologics and cell and gene therapy (CGT), plus facility operations that keep critical environments in spec.

Key Industries Served

01

Overview

• Biopharma manufacturers and distributors • Hospital systems, research campuses, specialty pharmacies • Contract development and manufacturing organizations (CDMOs)

Key Industries Served

01

Overview

• Biopharma manufacturers and distributors • Hospital systems, research campuses, specialty pharmacies • Contract development and manufacturing organizations (CDMOs)

Key Industries Served

01

Overview

• Biopharma manufacturers and distributors • Hospital systems, research campuses, specialty pharmacies • Contract development and manufacturing organizations (CDMOs)

Representative Work

02

Overview

• –20 °C/–80 °C storage with continuous monitoring and audit trails • Time- and temperature-validated courier routes • Facility mechanical/electrical/plumbing (MEP) and heating/ventilation/air conditioning (HVAC) operations and maintenance

Representative Work

02

Overview

• –20 °C/–80 °C storage with continuous monitoring and audit trails • Time- and temperature-validated courier routes • Facility mechanical/electrical/plumbing (MEP) and heating/ventilation/air conditioning (HVAC) operations and maintenance

Representative Work

02

Overview

• –20 °C/–80 °C storage with continuous monitoring and audit trails • Time- and temperature-validated courier routes • Facility mechanical/electrical/plumbing (MEP) and heating/ventilation/air conditioning (HVAC) operations and maintenance

Market Snapshot

03

Overview

Growth driven by biologics volume, specialty distribution, and quality-system requirements.

Market Snapshot

03

Overview

Growth driven by biologics volume, specialty distribution, and quality-system requirements.

Market Snapshot

03

Overview

Growth driven by biologics volume, specialty distribution, and quality-system requirements.

Why Rosewood

04

Overview

• Compliance culture aligned with documentation and audit needs • Ability to integrate sensor data with NOC/SOC observability • Portfolio access to lift/haul for large medical equipment installs

Why Rosewood

04

Overview

• Compliance culture aligned with documentation and audit needs • Ability to integrate sensor data with NOC/SOC observability • Portfolio access to lift/haul for large medical equipment installs

Why Rosewood

04

Overview

• Compliance culture aligned with documentation and audit needs • Ability to integrate sensor data with NOC/SOC observability • Portfolio access to lift/haul for large medical equipment installs

Platform Synergies

05

Overview

• Information and communications technology (ICT) teams enable secure connectivity and monitoring • Site Services supports shutdowns and clean phases for upgrades

Platform Synergies

05

Overview

• Information and communications technology (ICT) teams enable secure connectivity and monitoring • Site Services supports shutdowns and clean phases for upgrades

Platform Synergies

05

Overview

• Information and communications technology (ICT) teams enable secure connectivity and monitoring • Site Services supports shutdowns and clean phases for upgrades

Market Pulse

Market Pulse

Market Pulse

$316B

$316B

$316B

(2024) Global cold-chain logistics market size.

7.2%

7.2%

7.2%

CAGR (’24–’30) Pharmaceutical CDMO market growth.

4.5%

4.5%

4.5%

CAGR (’25–’34) Global healthcare construction growth.

Let’s Talk

Founders, bankers, and operators—let’s discuss succession planning, growth capital, or partnership opportunities.

Let’s Talk

Founders, bankers, and operators—let’s discuss succession planning, growth capital, or partnership opportunities.

Let’s Talk

Founders, bankers, and operators—let’s discuss succession planning, growth capital, or partnership opportunities.

Healthcare &
Life Sciences Infrastructure

Healthcare &
Life Sciences Infrastructure

Healthcare &
Life Sciences Infrastructure

Temperature integrity. Clinical certainty.

Good Distribution Practice (GDP)-compliant storage and validated transport for biologics and cell and gene therapy (CGT), plus facility operations that keep critical environments in spec.

Key Industries Served

01

Overview

• Biopharma manufacturers and distributors • Hospital systems, research campuses, specialty pharmacies • Contract development and manufacturing organizations (CDMOs)

Key Industries Served

01

Overview

• Biopharma manufacturers and distributors • Hospital systems, research campuses, specialty pharmacies • Contract development and manufacturing organizations (CDMOs)

Key Industries Served

01

Overview

• Biopharma manufacturers and distributors • Hospital systems, research campuses, specialty pharmacies • Contract development and manufacturing organizations (CDMOs)

Representative Work

02

Overview

• –20 °C/–80 °C storage with continuous monitoring and audit trails • Time- and temperature-validated courier routes • Facility mechanical/electrical/plumbing (MEP) and heating/ventilation/air conditioning (HVAC) operations and maintenance

Representative Work

02

Overview

• –20 °C/–80 °C storage with continuous monitoring and audit trails • Time- and temperature-validated courier routes • Facility mechanical/electrical/plumbing (MEP) and heating/ventilation/air conditioning (HVAC) operations and maintenance

Representative Work

02

Overview

• –20 °C/–80 °C storage with continuous monitoring and audit trails • Time- and temperature-validated courier routes • Facility mechanical/electrical/plumbing (MEP) and heating/ventilation/air conditioning (HVAC) operations and maintenance

Market Snapshot

03

Overview

Growth driven by biologics volume, specialty distribution, and quality-system requirements.

Market Snapshot

03

Overview

Growth driven by biologics volume, specialty distribution, and quality-system requirements.

Market Snapshot

03

Overview

Growth driven by biologics volume, specialty distribution, and quality-system requirements.

Why Rosewood

04

Overview

• Compliance culture aligned with documentation and audit needs • Ability to integrate sensor data with NOC/SOC observability • Portfolio access to lift/haul for large medical equipment installs

Why Rosewood

04

Overview

• Compliance culture aligned with documentation and audit needs • Ability to integrate sensor data with NOC/SOC observability • Portfolio access to lift/haul for large medical equipment installs

Why Rosewood

04

Overview

• Compliance culture aligned with documentation and audit needs • Ability to integrate sensor data with NOC/SOC observability • Portfolio access to lift/haul for large medical equipment installs

Platform Synergies

05

Overview

• Information and communications technology (ICT) teams enable secure connectivity and monitoring • Site Services supports shutdowns and clean phases for upgrades

Platform Synergies

05

Overview

• Information and communications technology (ICT) teams enable secure connectivity and monitoring • Site Services supports shutdowns and clean phases for upgrades

Platform Synergies

05

Overview

• Information and communications technology (ICT) teams enable secure connectivity and monitoring • Site Services supports shutdowns and clean phases for upgrades

Market Pulse

Market Pulse

Market Pulse

$316B

$316B

$316B

(2024) Global cold-chain logistics market size.

7.2%

7.2%

7.2%

CAGR (’24–’30) Pharmaceutical CDMO market growth.

4.5%

4.5%

4.5%

CAGR (’25–’34) Global healthcare construction growth.

Let’s Talk

Founders, bankers, and operators—let’s discuss succession planning, growth capital, or partnership opportunities.

Let’s Talk

Founders, bankers, and operators—let’s discuss succession planning, growth capital, or partnership opportunities.

Let’s Talk

Founders, bankers, and operators—let’s discuss succession planning, growth capital, or partnership opportunities.

Healthcare &
Life Sciences Infrastructure

Healthcare &
Life Sciences Infrastructure

Healthcare &
Life Sciences Infrastructure

Temperature integrity. Clinical certainty.

Good Distribution Practice (GDP)-compliant storage and validated transport for biologics and cell and gene therapy (CGT), plus facility operations that keep critical environments in spec.

Key Industries Served

01

Overview

• Biopharma manufacturers and distributors • Hospital systems, research campuses, specialty pharmacies • Contract development and manufacturing organizations (CDMOs)

Key Industries Served

01

Overview

• Biopharma manufacturers and distributors • Hospital systems, research campuses, specialty pharmacies • Contract development and manufacturing organizations (CDMOs)

Key Industries Served

01

Overview

• Biopharma manufacturers and distributors • Hospital systems, research campuses, specialty pharmacies • Contract development and manufacturing organizations (CDMOs)

Representative Work

02

Overview

• –20 °C/–80 °C storage with continuous monitoring and audit trails • Time- and temperature-validated courier routes • Facility mechanical/electrical/plumbing (MEP) and heating/ventilation/air conditioning (HVAC) operations and maintenance

Representative Work

02

Overview

• –20 °C/–80 °C storage with continuous monitoring and audit trails • Time- and temperature-validated courier routes • Facility mechanical/electrical/plumbing (MEP) and heating/ventilation/air conditioning (HVAC) operations and maintenance

Representative Work

02

Overview

• –20 °C/–80 °C storage with continuous monitoring and audit trails • Time- and temperature-validated courier routes • Facility mechanical/electrical/plumbing (MEP) and heating/ventilation/air conditioning (HVAC) operations and maintenance

Market Snapshot

03

Overview

Growth driven by biologics volume, specialty distribution, and quality-system requirements.

Market Snapshot

03

Overview

Growth driven by biologics volume, specialty distribution, and quality-system requirements.

Market Snapshot

03

Overview

Growth driven by biologics volume, specialty distribution, and quality-system requirements.

Why Rosewood

04

Overview

• Compliance culture aligned with documentation and audit needs • Ability to integrate sensor data with NOC/SOC observability • Portfolio access to lift/haul for large medical equipment installs

Why Rosewood

04

Overview

• Compliance culture aligned with documentation and audit needs • Ability to integrate sensor data with NOC/SOC observability • Portfolio access to lift/haul for large medical equipment installs

Why Rosewood

04

Overview

• Compliance culture aligned with documentation and audit needs • Ability to integrate sensor data with NOC/SOC observability • Portfolio access to lift/haul for large medical equipment installs

Platform Synergies

05

Overview

• Information and communications technology (ICT) teams enable secure connectivity and monitoring • Site Services supports shutdowns and clean phases for upgrades

Platform Synergies

05

Overview

• Information and communications technology (ICT) teams enable secure connectivity and monitoring • Site Services supports shutdowns and clean phases for upgrades

Platform Synergies

05

Overview

• Information and communications technology (ICT) teams enable secure connectivity and monitoring • Site Services supports shutdowns and clean phases for upgrades

Market Pulse

Market Pulse

Market Pulse

$316B

$316B

$316B

(2024) Global cold-chain logistics market size.

7.2%

7.2%

7.2%

CAGR (’24–’30) Pharmaceutical CDMO market growth.

4.5%

4.5%

4.5%

CAGR (’25–’34) Global healthcare construction growth.

Let’s Talk

Founders, bankers, and operators—let’s discuss succession planning, growth capital, or partnership opportunities.

Let’s Talk

Founders, bankers, and operators—let’s discuss succession planning, growth capital, or partnership opportunities.

Let’s Talk

Founders, bankers, and operators—let’s discuss succession planning, growth capital, or partnership opportunities.